Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-8651-4_5
Reference80 articles.
1. Lee JJ, Yokota T (2013) Antisense therapy in neurology. J Pers Med 3(3):144–176. https://doi.org/10.3390/jpm3030144
2. Guncay A, Yokota T (2015) Antisense oligonucleotide drugs for Duchenne muscular dystrophy: how far have we come and what does the future hold? Future Med Chem 7(13):1631–1635. https://doi.org/10.4155/fmc.15.116
3. Vickers TA, Zhang H, Graham MJ et al (2006) Modification of MyD88 mRNA splicing and inhibition of IL-1beta signaling in cell culture and in mice with a 2'-O-methoxyethyl-modified oligonucleotide. J Immunol 176(6):3652–3661
4. (2016) Eteplirsen (Exondys 51) for Duchenne muscular dystrophy. Med Lett Drugs Ther 58 (1507):145–146
5. Shorrock HK, Gillingwater TH, Groen EJN. (2018) Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy. Drugs 78(3):293–305
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Deciphering HERG mutation in long QT syndrome type 2 using antisense oligonucleotide–mediated techniques: Lessons from cystic fibrosis;Heart Rhythm;2023-08
2. Ensemble-Learning and Feature Selection Techniques for Enhanced Antisense Oligonucleotide Efficacy Prediction in Exon Skipping;Pharmaceutics;2023-06-24
3. A presumed missense variant in the U2AF2 gene causes exon skipping in neurodevelopmental diseases;Journal of Human Genetics;2023-02-07
4. Recruitment of a splicing factor to the nuclear lamina for its inactivation;Communications Biology;2022-07-22
5. Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases;Advanced Science;2022-07-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3